Research Guides
Peptide Reconstitution:
The Complete Protocol
A step-by-step guide to reconstituting research peptides correctly — solvent selection, injection technique, concentration calculations, multi-use vial strategy, labeling, and safe disposal. Built for researchers who need to get it right.
What is reconstitution?
Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder in a liquid solvent to create an injectable or working solution. Done correctly, it preserves compound integrity and ensures accurate dosing. Done incorrectly, it introduces contamination, degrades the peptide, or produces inaccurate concentrations.
Lyophilized peptides are stable powders — often visually indistinguishable regardless of compound. The process of converting them into a working solution requires attention to four variables: solvent choice, technique, concentration math, and storage. Each of these affects compound integrity in ways that directly impact experimental validity.
This guide covers each variable in depth, with worked concentration calculations for common Nexphoria catalog compounds.
Choosing Your Solvent
Solvent choice is the single most consequential decision in reconstitution. The wrong solvent can cause precipitation, degradation, or cytotoxicity in your experimental system. The following table covers the five solvents used in peptide research, their appropriate use cases, and trade-offs.
Bacteriostatic Water (0.9% benzyl alcohol)
Best for: Most research peptides: BPC-157, TB-500, GHRPs, GLP-1 analogs, GHK-Cu
Advantages
- +Multi-use vials (up to 4–6 weeks refrigerated)
- +Benzyl alcohol inhibits microbial growth
- +Physiologically compatible
- +Commercially available, sterile
Limitations
- −Not suitable for cells sensitive to benzyl alcohol
- −Benzyl alcohol can be irritating at high volumes in vivo
Recommendation: Default choice for most injectable research protocols.
Sterile Water for Injection (WFI)
Best for: Single-use aliquots, cell culture (with dilution), sensitive compounds
Advantages
- +Purest option — no preservatives or additives
- +Compatible with all cell culture systems
- +Predictable buffer behavior
Limitations
- −No preservative — single-use only, use within 5–7 days refrigerated
- −Microbial contamination risk if vial re-entered
- −More vials needed for research programs
Recommendation: Use when BAC water preservative is a study variable or when aliquoting for freeze storage.
0.1% Acetic Acid
Best for: IGF-1, EGF, HGH, GH, peptides with cysteine residues, hydrophobic peptides
Advantages
- +Stabilizes acidic peptides that precipitate at neutral pH
- +Standard for IGF-1 and growth hormone reconstitution
- +Prevents aggregation of hydrophobic sequences
Limitations
- −Must be diluted in PBS or buffer before cell culture use (acidity is cytotoxic at high concentration)
- −Not suitable for basic peptides — check peptide pI
Recommendation: Required for specific peptides like IGF-1. Check whether your peptide precipitates at pH 7 before choosing.
DMSO (Dimethyl Sulfoxide)
Best for: Poorly water-soluble peptides, cyclic peptides, some non-peptide compounds
Advantages
- +High solubilizing power for hydrophobic molecules
- +Penetration enhancer for topical protocols
Limitations
- −Cytotoxic above ~0.5% v/v in cell culture — must dilute extensively
- −Strong carrier effect — alters membrane permeability
- −Taste/odor issues with in vivo use
- −Reacts with some plastic labware (use glass)
Recommendation: Last resort for poorly soluble compounds only. Dilute to <0.1% DMSO in final working solution. Avoid for standard peptides.
PBS (Phosphate-Buffered Saline)
Best for: Direct cell culture use; dilution of acetic acid stock solutions
Advantages
- +Physiological pH and osmolarity
- +Cell-compatible
- +Standard lab reagent
Limitations
- −No preservative — single-use vials only
- −Phosphate can precipitate with calcium-containing buffers
Recommendation: Good for diluting peptide stocks before cell culture. Not ideal as primary reconstitution solvent for lyophilized vials.
Quick Reference: Solvent Decision Tree
- → Standard injectable peptide (BPC-157, TB-500, GHRPs, GLP-1 analogs): Use bacteriostatic water
- → Cell culture or single-use: Use sterile water, then dilute in PBS/medium
- → IGF-1, EGF, growth hormone: Use 0.1% acetic acid, dilute in PBS before use
- → Peptide won't dissolve in water: Try 0.1% acetic acid or DMSO as last resort
- → GHK-Cu: Use sterile water (water-soluble; no organic solvent needed)
Reconstitution Technique
Even with the correct solvent, poor injection technique can introduce contamination or degrade the peptide through mechanical shear. The following steps apply to all lyophilized peptide vials.
Equilibrate the vial to room temperature
Remove the vial from the refrigerator or freezer and allow it to sit at room temperature for 5–10 minutes before opening. Opening a cold vial in a warm environment causes atmospheric moisture to condense inside the vial — introducing water directly onto the powder before you control the solvent volume. This is the most commonly skipped step.
Prepare your syringe and workspace
Draw up the measured volume of solvent into a sterile syringe. Use a 21–23 gauge needle for ease of draw; you can switch to a smaller gauge (25–27 gauge) for injection. Wipe the rubber septum of both the solvent vial and the peptide vial with an isopropyl alcohol swab and allow to air-dry completely (20–30 seconds) before inserting the needle.
Inject solvent against the vial wall — not onto the powder
This is the most important technical step. Direct the needle tip at an angle so the solvent stream hits the inner glass wall of the vial, then runs down to wet the peptide from the sides. Injecting directly onto the lyophilized powder creates a high-velocity liquid jet that can mechanically shear the peptide structure and causes foaming. A wall-directed injection minimizes mechanical stress and produces a cleaner reconstitution.
Swirl gently — never vortex
After the solvent is fully added, hold the vial between your fingers and gently roll or swirl it in a circular motion. Allow the lyophilized cake to dissolve at its own rate — most standard peptides dissolve within 30–90 seconds. For larger peptides (>5 mg vials, larger sequences), gentle inversion 10–15 times over 2–3 minutes is appropriate. Vortexing creates vigorous mechanical agitation that generates foam and denatures larger peptide structures. Do not shake.
Inspect the solution
A correctly reconstituted peptide solution should be clear to slightly opalescent, free of visible particles or undissolved material. Cloudiness can indicate precipitation, aggregation, or the wrong solvent choice. Color is compound-specific: GHK-Cu solutions are blue-violet; most peptides are colorless to pale yellow. If the solution remains cloudy after 3 minutes of gentle swirling, try adding a small additional volume of solvent and wait — do not heat.
Do not add pressure or release vacuum
Research peptide vials are often under vacuum (as part of the lyophilization process). When inserting the needle of the solvent syringe, the vacuum will draw solvent in naturally — use this property. Do not force the plunger aggressively. For large volumes, insert a second venting needle (or 23g needle with no syringe) to equalize pressure, then add solvent with the primary syringe.
✓ Do
- Allow vial to reach room temperature first
- Wipe septum with IPA before each needle insertion
- Inject solvent against the vial wall
- Swirl gently in slow circles
- Use sterile technique throughout
- Label vial immediately after reconstitution
✗ Don't
- Open cold vials — condensation enters
- Inject solvent directly onto powder
- Vortex or shake vigorously
- Heat to dissolve
- Use tap water or non-sterile solvent
- Leave unlabeled reconstituted vials
Concentration Calculations
The fundamental calculation is straightforward. The formula is:
The Core Formula
Volume (mL) = Amount (mg or mcg) ÷ Target Concentration (mg/mL or mcg/mL)
Ensure your units are consistent. 1 mg = 1,000 mcg. 1 mL = 100 units on a 100IU/mL insulin syringe.
Unit Conversions
| From | To | Multiply by |
|---|---|---|
| milligrams (mg) | micrograms (mcg) | 1,000 |
| micrograms (mcg) | milligrams (mg) | 0.001 |
| milliliters (mL) | Units (100 IU/mL syringe) | 100 |
| Units (100 IU/mL syringe) | milliliters (mL) | 0.01 |
| mL (50 IU/mL syringe) | Units | 50 |
| mg/mL | mcg/mL | 1,000 |
Choosing a Working Concentration
The target concentration you choose determines how much liquid you inject per dose. Practical constraints to consider:
- →Injection volume for rodents: Subcutaneous injection volumes in mice should not exceed 0.5–1 mL; for rats, up to 2 mL SC. Higher concentrations reduce injection volume, which is preferable.
- →Measurable dose volume: You need enough volume to measure accurately with your syringe. A dose of 5 mcL is difficult to draw accurately; 50–200 mcL is manageable with insulin syringes.
- →Stability at concentration: Higher concentrations can increase aggregation risk for some larger peptides. If your compound becomes cloudy at high concentration, dilute and refrigerate rather than increasing solvent ratio.
- →Vial reuse: If multiple subjects will be dosed from one vial, a higher concentration means more doses per vial, reducing vial penetrations (contamination risk with each entry).
Worked Examples
Concrete step-by-step calculations for four common Nexphoria catalog compounds.
BPC-157, 5 mg vial → 500 mcg/mL working solution
- 1.Target concentration: 500 mcg/mL
- 2.Vial content: 5 mg = 5,000 mcg
- 3.Volume needed: 5,000 mcg ÷ 500 mcg/mL = 10 mL BAC water
- 4.Add 10 mL bacteriostatic water to the 5 mg vial
- 5.Each 1 mL of solution = 500 mcg BPC-157
- 6.Each 0.1 mL (10 units on insulin syringe) = 50 mcg
- 7.Doses per vial: 5,000 mcg ÷ 50 mcg per dose = 100 doses at 50 mcg
Note
Use 1 mL insulin syringes (100 IU/mL = 100 units). Inject 10 units per 50 mcg dose.
Semaglutide, 2 mg vial → 0.5 mg/mL working solution
- 1.Target concentration: 0.5 mg/mL
- 2.Vial content: 2 mg
- 3.Volume needed: 2 mg ÷ 0.5 mg/mL = 4 mL BAC water
- 4.Add 4 mL bacteriostatic water to the 2 mg vial
- 5.Each 1 mL = 0.5 mg semaglutide
- 6.Each 0.2 mL (20 units on insulin syringe) = 0.1 mg
- 7.Doses per vial: 2 mg ÷ 0.1 mg per dose = 20 doses at 0.1 mg
Note
Common research starting dose is 0.1–0.25 mg. Titrate based on study protocol.
TB-500, 10 mg vial → 2 mg/mL working solution
- 1.Target concentration: 2 mg/mL
- 2.Vial content: 10 mg = 10,000 mcg
- 3.Volume needed: 10 mg ÷ 2 mg/mL = 5 mL BAC water
- 4.Add 5 mL bacteriostatic water to the 10 mg vial
- 5.Each 1 mL = 2 mg = 2,000 mcg TB-500
- 6.Each 0.1 mL = 200 mcg
- 7.Doses per vial: 10 mg ÷ 2 mg per dose = 5 doses at 2 mg
Note
TB-500 dissolves readily. Gently swirl — the lyophilized cake should fully dissolve within 60 seconds.
GHK-Cu, 100 mg vial → 10 mg/mL stock + cell culture dilution
- 1.Reconstitution: 100 mg ÷ 10 mg/mL = 10 mL sterile water
- 2.Stock concentration: 10 mg/mL = 10,000 mcg/mL = ~24.8 mM (MW 403.9)
- 3.For cell culture (target 100 nM working concentration):
- Step 1: 10 mg/mL → 0.1 mg/mL intermediate (1:100 dilution in PBS)
- Step 2: 0.1 mg/mL → target nM in culture medium (serial dilution)
- Final: add diluted stock to cell culture medium at 0.1–1% v/v max
- 7.Aliquot the 10 mg/mL stock into 200 mcL single-use tubes before freezing
Note
For GHK-Cu cell culture work, prepare fresh dilutions from frozen stock each experiment. The copper complex is stable frozen but avoid repeated freeze-thaw.
Use the Reconstitution Calculator
Prefer an interactive calculator? Enter your vial size, target concentration, and dose — the calculator handles the math and outputs BAC water volume, doses per vial, and volume per dose.
Open Calculator →Multi-Use vs. Single-Use Vial Strategy
Once reconstituted, you must decide whether to use the vial across multiple doses (multi-use) or aliquot into single-use volumes before freezing. Each strategy has trade-offs.
Multi-Use Vial
Keep the reconstituted vial refrigerated at 4°C and draw doses from it over the stability window (3–4 weeks with BAC water; 5–7 days with sterile water).
Best when:
- • BAC water (preservative) was used for reconstitution
- • Study protocol requires daily or frequent dosing
- • Total doses will be consumed within 3–4 weeks
- • Each vial entry uses a fresh needle and proper aseptic technique
Aliquot and Freeze
After reconstitution, immediately divide the solution into single-dose or session-dose volumes in sterile microcentrifuge tubes and store at −20°C. Thaw one aliquot per use session.
Best when:
- • Sterile water (no preservative) was used
- • Study spans more than 3–4 weeks
- • Compound is expensive or limited — each vial entry risks contamination
- • You need to run reproducible dose-matched sessions over long timelines
Critical: Avoid Repeated Freeze-Thaw Cycles
Each freeze-thaw cycle introduces ice crystal formation that can mechanically cleave peptide bonds and cause aggregation. For a peptide frozen in a large aliquot that is thawed and re-frozen 5 times, effective concentration can drop 15–30% through aggregation losses. Aliquot into single-use volumes before the first freeze. Thaw what you need; discard unused thawed solution at end of session.
Labeling Protocol
Unlabeled reconstituted vials are a source of errors and safety risks. A complete label prevents dose errors, allows accurate stability tracking, and supports audit trails in formal research settings.
Minimum Label Contents
For GLP printout labels, use a permanent marker rated for freezer use (standard ballpoint ink smears at −20°C). Parafilm over the label protects it in humid refrigerators. For amber vials or light-sensitive compounds (GHK-Cu, PT-141, Melanotan II), additionally wrap in aluminum foil.
Safe Disposal
Research peptide solutions and associated sharps require appropriate disposal. While specific regulations vary by jurisdiction and institution, the following represents standard best practices for responsible laboratory disposal.
Expired or unused reconstituted solution
Peptide solutions past their stability window should not be used. For disposal, dilute significantly with water and dispose via sink drain (trace peptide concentrations are metabolically degraded in standard wastewater treatment). Do not pour concentrated solutions directly into drains in institutional settings — follow your institution's chemical waste policy.
Sharps (needles, syringes)
All needles and syringes used in the reconstitution process are sharps waste regardless of whether the compound is hazardous. Use an approved sharps container (puncture-resistant, labeled). Do not recap needles after use. Seal sharps containers when 3/4 full and dispose according to your local regulations (in the US: contact your municipal waste authority or use a mail-back sharps program).
Empty lyophilized vials
Empty glass vials that contained research peptides are not classified as hazardous waste in most jurisdictions. Residual peptide amounts are trace and biologically inert after standard lyophilization handling. Dispose as glass waste per your institution's policy, or in a puncture-resistant container if not using a dedicated glass waste stream.
DMSO-containing solutions
DMSO waste requires special handling because DMSO penetrates skin and can carry dissolved compounds with it. Do not pour DMSO waste solutions into standard drains in institutional settings. Collect in a labeled DMSO waste container and dispose as chemical waste.
Animal research waste
Bedding, tissues, and biological materials from animals receiving research peptides follow your institution's biological waste protocol. Most research peptides are catabolized to amino acids and do not pose secondary hazard in biological waste streams, but institutional policy governs.
Related Resources
Reconstitution Calculator
Interactive calculator: vial size → BAC water volume, doses per vial, volume per dose
BAC Water Guide
What bacteriostatic water is, why benzyl alcohol matters, and storage after mixing
Peptide Storage Guide
Temperature requirements per compound, freeze-thaw limits, container recommendations
Research Use Only. All compounds supplied by Nexphoria are intended for laboratory research purposes only. They are not approved by the FDA for human or veterinary use and are not intended to diagnose, treat, cure, or prevent any disease or condition. This guide is provided for informational purposes only. Researchers are responsible for compliance with applicable institutional, local, state, and federal regulations governing the purchase, storage, use, and disposal of research chemicals.